Pelvic floor myofascial pain syndrome
Conditions
Interventions
Magnetic stimulation treatment group:Pelvic floor magnetic stimulation therapy
Control group:Pelvic floor pseudomagnetic stimulation therapy
Sponsors
The Seventh Affiliated Hospital of Sun Yat sen University
Eligibility
Sex/Gender
Female
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-60 year female with sexual life history, without cognitive impairment, and can understand and complete treatment projects; 2. Diagnosed as pelvic floor myofascial pain syndrome and no definite pathological changes were found by pelvic floor ultrasound; 3. Did not receive any relevant treatment 3 months before the visit; 4. No serious internal and external diseases; 5. Obtain informed consent
Exclusion criteria
Exclusion criteria: 1. Complicated with vaginal bleeding and acute pelvic inflammatory disease; 2. Pregnancy, malignant tumor, radiotherapy and chemotherapy; 3. Patients with cardiac pacemaker, defibrillation cardioverter and metal intrauterine device; 4. Patients with severe cardiopulmonary insufficiency, liver failure and bleeding tendency; 5. Nervous system diseases (such as stroke, epilepsy, Parkinson's disease, multiple sclerosis); 6. People who are allergic to magnetic stimulation; 7. Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS (Visual Analogue Scale/Score) score changes of pelvic floor muscle tenderness before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS (Visual Analogue Scale/Score) score changes of subjective pain of patients before and after treatment;Glazer EMG evaluation before and after treatment results;Hypoechoic nodule in pelvic floor ultrasonic examination at pelvic floor tenderness points before and after treatment and the change of nodule size before and after treatment;Changes in the number of hypoechoic nodules at the tenderness points of the pelvic floor examined by pelvic ultrasound before and after treatment;Changes in the questionnaire of pelvic floor muscle dysfunction before and after treatment (PFDI-20);Changes of female sexual function index (FSFI score) before and after treatment;Changes of urinary incontinence before and after treatment; | — |
Countries
China
Contacts
Public ContactLi Tian
The Seventh Affiliated Hospital of Sun Yat sen University
Outcome results
None listed